(102) reported that IL-37 did not affect the production of Th2-associated cytokines in an HDM-induced acute asthma model, they observed a significant reduction in eosinophilia, CCL11 production, and airway hyperresponsiveness (AHR) when IL-37 was administered during the challenge phase. This evidence concerns the gene IL37 and airway hyperresponsiveness.